Pharmacovigilance Software Market to Reach USD 415.42 Million by 2033 at 7.4% CAGR; Asia Pacific Leads Growth with 30% Share - Key Players: Oracle, IQVIA, ArisGlobal, Veeva Systems, IBM

The global pharmacovigilance software market reached USD 218.95 million in 2024 and is expected to reach USD 415.42 million by 2033, growing at a CAGR of 7.4% during the forecast period 2025 to 2033. The market is witnessing steady growth driven by the increasing focus on drug safety monitoring and regulatory compliance across the pharmaceutical and biotechnology industries.

Market growth is fueled by the rising volume of adverse drug reaction (ADR) reports, increasing clinical trial activities, and stringent regulatory requirements for post-market surveillance of drugs. Pharmacovigilance software enables efficient data collection, signal detection, and risk assessment, helping organizations ensure patient safety and compliance with global health authorities. Additionally, the growing adoption of cloud-based solutions and automation technologies is further accelerating market expansion.

Pharmacovigilance software plays a critical role in modern drug development and lifecycle management by streamlining safety data management and improving reporting accuracy. Advanced features such as real-time analytics, artificial intelligence, and machine learning are enhancing signal detection and decision-making processes. Furthermore, increasing investments in digital transformation within the life sciences sector, along with the expansion of outsourcing services and global drug pipelines, are positioning the pharmacovigilance software market as a key component of the pharmaceutical safety ecosystem.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/pharmacovigilance-software-market?sai-v

Key Developments

✅ February 2026: Across North America, Europe, and Asia Pacific, increasing regulatory pressure from global health authorities and rising incidence of adverse drug reactions significantly accelerated demand for pharmacovigilance software solutions for real-time drug safety monitoring.

✅ January 2026: Globally, advancements in AI-driven signal detection, automated case processing, and real-time adverse event reporting systems improved safety surveillance efficiency and enabled faster regulatory compliance across pharmaceutical pipelines.

✅ December 2025: Leading companies such as Oracle Corporation, IBM Corporation, Veeva Systems Inc., IQVIA Holdings Inc., and ArisGlobal LLC intensified innovation in cloud-based pharmacovigilance platforms, integrated safety databases, and end-to-end drug safety management systems.

✅ November 2025: Increasing adoption of cloud-based pharmacovigilance platforms improved scalability, reduced operational costs, and enhanced global collaboration between pharmaceutical companies, CROs, and regulatory agencies.

✅ October 2025: Companies intensified investments in AI, natural language processing (NLP), and machine learning-based pharmacovigilance tools to enhance automated adverse event detection and improve data accuracy in safety reporting workflows.

✅ September 2025: Across key regions including the United States, Europe, India, and Japan, strengthening pharmacovigilance regulations, expanding clinical trial activity, and increasing drug approvals significantly supported market growth and digital transformation.

The pharmacovigilance software market is rapidly shifting toward fully automated, AI-enabled safety ecosystems, integrating real-world data, EHR mining, and predictive analytics to proactively detect drug risks before they escalate.

Key Players

Ennov | Oracle | ArisGlobal | EXTEDO | Clinevo Technologies | IQVIA | Quanticate | Cloudbyz | Flex Databases | Others

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pharmacovigilance-software-market?sai-v

Market Drivers

Increasing regulatory requirements for drug safety monitoring and adverse event reporting are significantly driving demand for pharmacovigilance software.

Rising global drug consumption and expanding pharmaceutical pipelines are increasing the need for continuous safety surveillance systems.

Growing clinical trial activities and post-marketing surveillance requirements are strengthening adoption of advanced PV platforms.

Shift toward cloud-based and AI-enabled solutions is improving scalability, real-time monitoring, and compliance efficiency.

Increasing focus on patient safety and reduction of medication-related risks is boosting software adoption across life sciences companies.

Rising outsourcing of pharmacovigilance services to CROs is accelerating demand for integrated digital platforms.

Growing need for data integration from EHRs, clinical trials, and real-world evidence sources is supporting market expansion.

Industry Developments

Rapid adoption of AI-driven pharmacovigilance systems for automated adverse event detection and case processing.

Expansion of cloud-based PV platforms enabling real-time global drug safety monitoring and faster regulatory reporting.

Increasing integration of large language models and machine learning for signal detection and case classification.

Strong shift toward end-to-end automated safety workflows including literature monitoring and report generation.

Growing use of real-world data and electronic health record integration to improve signal accuracy.

Rising investments and partnerships between tech firms and pharma companies to modernize safety systems.

Development of modular, scalable PV suites supporting global regulatory compliance across multiple regions.

Regional Insights

North America 32% share: "Leads the market due to strong regulatory frameworks, high adoption of digital health solutions, and presence of major pharmaceutical companies."

Europe 28% share: "Growth driven by strict pharmacovigilance regulations and advanced healthcare IT infrastructure."

Asia Pacific 30% share: "Fastest-growing region supported by expanding pharmaceutical manufacturing, clinical trials, and regulatory modernization."

Latin America 6% share: "Emerging growth driven by improving drug safety regulations and increasing pharma investments."

Middle East & Africa 4% share: "Gradual growth supported by evolving regulatory systems and expanding healthcare infrastructure."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/pharmacovigilance-software-market?sai-v

Key Segments

➥ By Functionality
Adverse Event Reporting Software: Represents the dominant segment, driven by regulatory requirements for timely detection, documentation, and reporting of drug safety events.

Drug Safety Audits Software: Represents a significant segment, supporting compliance checks, risk assessment, and regulatory inspections across pharmaceutical operations.

Issue Tracking Software: Represents a growing segment, enabling efficient monitoring, management, and resolution of safety-related issues throughout the drug lifecycle.

Fully Integrated Software: Represents a rapidly growing segment, driven by demand for end-to-end pharmacovigilance solutions that combine reporting, analytics, and compliance in a single platform.

➥ By Delivery Mode
On-demand / Cloud-based (SaaS) Delivery Mode: Represents the dominant segment, driven by scalability, lower upfront costs, real-time access, and increasing digital transformation in life sciences.

On-premise Delivery Mode: Represents a significant segment, preferred by large enterprises requiring greater control over sensitive safety data and regulatory compliance.

➥ By End-User
Pharma and Biotech Companies: Represent the dominant segment, driven by strict regulatory compliance requirements and high volume of drug safety monitoring activities.

Contract Research Organizations (CROs): Represent a significant segment, supporting outsourced clinical trials and pharmacovigilance operations for pharmaceutical companies.

Business Process Outsourcing (BPO) Firms: Represent a growing segment, offering cost-effective pharmacovigilance services and data management solutions.

Other Pharmacovigilance Service Providers: Represent a notable segment, including specialized safety monitoring firms and regulatory consulting organizations.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.